Drugs
Conditions
News and resources
MIMS Supported ResourcesNICE recommends further treatment option for underserved heart failure population
In reversal of its initial recommendation, NICE has issued final draft guidance recommending empagliflozin (Jardiance) as an option for adults with symptomatic chronic heart failure with preserved or mildly reduced ejection fraction.
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.